Exogenesis Corporation

Exogenesis Corporation is a privately-held, venture capital backed company developing and commercializing proprietary nanoscale surface modification and surface control technologies which have application in improving the safety and performance of implantable medical devices and improving the performance of optics, glass and a variety of substrates used in the laser, memory and semiconductor industries. It has developed advanced technology and processing protocols for nano-scale surface engineering of implantable medical devices. Exogenesis NanoAccel technology has the unique ability to produce important atomic level surface modification effects without coatings or additives. Exogenesis acquired the exclusive worldwide rights to GCIB intellectual property for biomedical applications and has subsequently developed a complementary particle beam processing technology called NanoAccel Accelerated Neutral Atom Beam (ANAB).